Ophthotech's Revenue Finance Round

Ophthotech raised a round of funding on May 29, 2013. Investors include Novo A/S.

Ophthotech is a biopharmaceutical company focusing on discovering, developing and commercializing first-in-class therapies for the treatment of major ophthalmic diseases. Ophthotech's lead compound Fo…

Articles about Ophthotech's Revenue Finance Round: